Evaluate the Safety and Efficacy of HDM1002 Tablets in Chinese Overweight and Obese Adults
Clinical trial NCT06885021 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06885021
- Sponsor
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-28
- Primary completion
- 2026-05-30
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.